Precigen Inc (PGEN)
1.33
+0.02
(+1.53%)
USD |
NASDAQ |
Apr 18, 16:00
1.34
+0.01
(+0.75%)
Pre-Market: 08:06
Precigen Cash from Operations (Quarterly): -15.77M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.77M |
| September 30, 2023 | -17.01M |
| June 30, 2023 | -15.77M |
| March 31, 2023 | -18.39M |
| December 31, 2022 | -15.40M |
| September 30, 2022 | -23.81M |
| June 30, 2022 | -7.053M |
| March 31, 2022 | -18.78M |
| December 31, 2021 | -14.59M |
| September 30, 2021 | -17.02M |
| June 30, 2021 | -7.776M |
| March 31, 2021 | -16.38M |
| December 31, 2020 | -16.47M |
| September 30, 2020 | -19.00M |
| June 30, 2020 | -13.80M |
| March 31, 2020 | -27.74M |
| December 31, 2019 | 26.76M |
| September 30, 2019 | -27.15M |
| June 30, 2019 | -33.40M |
| March 31, 2019 | -43.23M |
| December 31, 2018 | -37.36M |
| September 30, 2018 | -28.82M |
| June 30, 2018 | -28.17M |
| March 31, 2018 | -29.89M |
| Date | Value |
|---|---|
| December 31, 2017 | -33.88M |
| September 30, 2017 | -22.01M |
| June 30, 2017 | -23.14M |
| March 31, 2017 | -24.69M |
| December 31, 2016 | -17.21M |
| September 30, 2016 | -15.73M |
| June 30, 2016 | -12.44M |
| March 31, 2016 | -3.609M |
| December 31, 2015 | 12.33M |
| September 30, 2015 | 52.90M |
| June 30, 2015 | -16.52M |
| March 31, 2015 | -13.04M |
| December 31, 2014 | -9.05M |
| September 30, 2014 | -6.637M |
| June 30, 2014 | -13.65M |
| March 31, 2014 | 9.479M |
| December 31, 2013 | -10.22M |
| September 30, 2013 | -15.85M |
| June 30, 2013 | -13.33M |
| March 31, 2013 | -14.28M |
| December 31, 2012 | -12.33M |
| September 30, 2012 | -15.28M |
| June 30, 2012 | -20.91M |
| March 31, 2012 | -13.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.40M
Minimum
Jun 2019
26.76M
Maximum
Dec 2019
-15.71M
Average
-16.47M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | -3.91M |
| HealthEquity Inc | 77.07M |
| Corvus Pharmaceuticals Inc | -5.167M |
| Oragenics Inc | -1.102M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 13.29M |
| Free Cash Flow | -68.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0675 |
| Free Cash Flow to Equity (Quarterly) | -16.81M |
| Free Cash Flow to Firm (Quarterly) | -16.81M |
| Free Cash Flow Yield | -21.11% |